Cool. What is their price target? Personally I think this stock with break $10 on an FDA yes vote in January. I base this on the very low number of shares outstanding and valuations I have seen for other biotechs on the verge of something great. I don't think $280 million cap would be much when they are looking at a good slice of a huge $14 Billion annual pie.